Short-Term Therapy With Rosiglitazone, a PPAR-γAgonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar Rats
ISRN Pharmacology
doi 10.5402/2012/130347
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2012
Authors
Publisher
Hindawi Limited